Stocks · News reference
Barclays Maintains Equal-Weight on Doximity, Raises Price Target to $27
Barclays analyst Glen Santangelo maintains Doximity (NYSE:DOCS) with a Equal-Weight and raises the price target from $20 to $27.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
What Investors Should Know of This Doximity Officer's Latest Insider Transaction
Doximity's Chief Accounting Officer Siddharth Sitaram sold 5,652 shares worth $140,400 in mid-August. The transaction was driven by routine tax obligations from option exercises and restricted stock unit vesting rather than a loss of confidence in the company. Sitaram retains significant equity holdings of 93,122 shares. The sale reflects standard tax-driven liquidity management common among executives.
Doximity Handed Its President 150,000 Options Last Month. Here's What the Latest Filing Signals for Investors
Doximity's president Steven Zatz sold 4,482 shares worth $111,154 on August 15 through a routine tax withholding transaction upon restricted stock unit vesting. Zatz retains 51,864 directly held shares valued at $1.29 million, but his significant upside exposure comes from 150,000 options granted in July with a $20.49 strike price that don't vest until July 2027. The timing is notable given Doximity's recent earnings showed 7% revenue growth but margin compression due to higher-than-expected AI compute costs, with the CFO characterizing this as a 'good problem' as AI search revenue recognition is expected in Q3.